Comprehensive Survival Analysis of a Cohort of Patients with Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

2013/02/07 by Peggy Sekula, Ariane Dunant, Maja Mockenhaupt +11 · 28 citations
Medicine · #Drug-Induced Adverse Reactions #Urticaria and Related Conditions #Heparin-Induced Thrombocytopenia and Thrombosis

paper · pdf · doi:10.1038/jid.2012.510

Citations

• ALDEN, an Algorithm for Assessment of Drug Causality in Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis: Comparison With Case–Control Analysis

Cited by

• Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults
• Cyclosporine Use in Epidermal Necrolysis Is Associated with an Important Mortality Reduction: Evidence from Three Different Approaches
• Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multicenter Retrospective Study of 377 Adult Patients from the United States
• Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. [europepmc]
• Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea. [europepmc]
• Review of Toxic Epidermal Necrolysis. [europepmc]
• Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. [europepmc]
• Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Concise Review with a Comprehensive Summary of Therapeutic Interventions Emphasizing Supportive Measures. [europepmc]
• Severe Delayed Cutaneous and Systemic Reactions to Drugs: A Global Perspective on the Science and Art of Current Practice. [europepmc]
• SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. [europepmc]
• Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins). [europepmc]
• An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity. [europepmc]
• Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Identified in the Electronic Health Record Allergy Module. [europepmc]
• Stevens-Johnson syndrome and toxic epidermal necrolysis with antiepileptic drugs: An analysis of the US Food and Drug Administration Adverse Event Reporting System. [europepmc]
• Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10. [europepmc]
• SJS/TEN 2019: From science to translation. [europepmc]
• Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN). [europepmc]
• Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review. [europepmc]
• Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis. [europepmc]
• Diagnostic Test Criteria for HLA Genotyping to Prevent Drug Hypersensitivity Reactions: A Systematic Review of Actionable HLA Recommendations in CPIC and DPWG Guidelines. [europepmc]
• Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis. [europepmc]
• Current Perspectives on Severe Drug Eruption. [europepmc]
• Assessment of Treatment Approaches and Outcomes in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Insights From a Pan-European Multicenter Study. [europepmc]
• Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management. [europepmc]
• Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis: The Role of Novel Inflammatory Markers and Proposed Revision of SCORTEN (Re-SCORTEN). [europepmc]
• Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome. [europepmc]
• Worldwide Prevalence of Antibiotic-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis. [europepmc]
• Spatial proteomics identifies JAKi as treatment for a lethal skin disease. [europepmc]